Abstract
We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID-19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.
Original language | English |
---|---|
Journal | Clinical Case Reports |
DOIs | |
Publication status | Accepted/In press - 2020 |
Keywords
- COVID-19
- pneumonia
- thalassemia
ASJC Scopus subject areas
- Medicine(all)